Vice President Business Development
Winterville, Nc, Us
Responsible for developing and commercializing next-generation, evidence-based, personalized healthcare to enable improved patient outcomes and more effective treatment decisions for critical illnesses. Responsibilities include prospecting and penetrating large payor accounts while building and expanding existing relationships with key decision makers. Convey market knowledge and voice of the customer into the organization to influence NantHealth’s product and innovation direction. GPS Cancer Test - GPS Cancer™ is a unique, comprehensive molecular test offered by NantHealth. GPS Cancer integrates whole genome (DNA) sequencing, whole transcriptome (RNA) sequencing, and quantitative proteomics, providing oncologists with a detailed molecular profile of a patient’s cancer to inform personalized treatment strategies. This unique test:• Includes whole genome sequencing of over 20,000 genes and 3 billion base pairs• Incorporates whole transcriptome sequencing of over 200,000 RNA transcripts• Leverages the power of quantitative proteomics• Compares a patient’s tumor genome to their normal genomeNantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS™, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.